2 article(s) from Ishitsuka, Yoichi
Graphical Abstract
Figure 1: Schematic representation for synthesis of multi-Lac-β-CD (5), β-CD (1), per-chloro-β-CD (2), per-az...
Figure 2: MALDI–TOFMS (A) and 1H NMR spectra (B) of multi-Lac-β-CD (DSL5.6)
Figure 3: Cytotoxicity of multi-Lac-β-CD in NPC-like HepG2 cells after treatment for 24 h. NPC-like HepG2 cel...
Figure 4: Binding curves of multi-Lac-β-CD (DSL5.6) (A) and β-CD (B) with peanut agglutinin (PNA). The bindin...
Figure 5: Intracellular distribution of TRITC-multi-Lac-β-CD (DSL5.6) in NPC-like HepG2 cells. Cells were inc...
Figure 6: Intracellular distribution of cholesterol in NPC-like HepG2 cells. (A) NPC-like HepG2 cells (1 × 105...
Graphical Abstract
Figure 1: Preparation scheme of Lac-β-CyD.
Figure 2: MALDI–TOF MS (A) and 1H NMR (B) spectra of Lac-β-CyD.
Figure 3: Cytotoxic activity of β-CyDs in U18666A-treated HepG2 cells after treatment for 24 h. U18666A-treat...
Figure 4: Cellular association of TRITC-Lac-β-CyD in U18666A-treated HepG2 cells after treatment for 24 h. Th...
Figure 5: Intracellular distribution of TRITC-Lac-β-CyD in U18666A-treated HepG2 cells. U18666A-treated HepG2...
Figure 6: Effect of concentration of Lac-β-CyD on intracellular level of free form of cholesterol in U18666A-...